Defending 'Salt Patents' In Hatch-Waxman Cases

After Pfizer Inc. v. Apotex Inc., 480 F.3d 1348 (Fed. Cir. 2007), reh'g denied, 488 F.3d 1377 (Fed. Cir. 2007) ("Norvasc decision"), there was an apparent drop in cases involving salt patents,...

Already a subscriber? Click here to view full article